CVE-2023-25931
CVE-2023-25931 is a medium-severity vulnerability in Medtronic Interstim X Clinician with a CVSS 3.x base score of 6.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-287.
Key facts
- Severity: Medium (CVSS 3.x base score 6.4)
- EPSS exploit prediction: 0% (18th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-287
- Affected product: Medtronic Interstim X Clinician
- Published:
- Last modified:
Description
Medtronic identified that the Pelvic Health clinician apps, which are installed on the Smart Programmer mobile device, have a password vulnerability that requires a security update to fix. Not updating could potentially result in unauthorized control of the clinician therapy application, which has greater control over therapy parameters than the patient app. Changes still cannot be made outside of the established therapy parameters of the programmer. For unauthorized access to occur, an individual would need physical access to the Smart Programmer.
Frequently asked questions
- What is CVE-2023-25931?
- Medtronic identified that the Pelvic Health clinician apps, which are installed on the Smart Programmer mobile device, have a password vulnerability that requires a security update to fix. Not updating could potentially result in unauthorized control of the clinician therapy application, which has greater control over therapy parameters than the patient app. Changes still cannot be made outside of the established therapy parameters of the programmer. For unauthorized access to occur, an individual would need physical access to the Smart Programmer.
- How severe is CVE-2023-25931?
- CVE-2023-25931 has a CVSS 3.x base score of 6.4, rated medium severity. It is exploitable over physical access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity high, and availability high.
- Is CVE-2023-25931 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (18th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2023-25931?
- CVE-2023-25931 primarily affects Medtronic Interstim X Clinician. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
- How do I fix CVE-2023-25931?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2023-25931 published?
- CVE-2023-25931 was published on 2023-03-01 and last updated on 2026-06-17.
References
Affected products (2)
- cpe:2.3:a:medtronic:interstim_x_clinician:a51300:*:*:*:*:*:*:*
- cpe:2.3:a:medtronic:micro_clinician:a51200:*:*:*:*:*:*:*
Other CWE-287 (Improper Authentication) vulnerabilities
- CVE-2026-45480 — Critical (CVSS 10.0): Improper authentication in Azure Active Directory allows an unauthorized attacker to elevate privileges over a network.
- CVE-2026-46389 — Critical (CVSS 10.0): UDS Identity Config builds the Keycloak configuration image (realm, plugins, theme, truststore, JARs) consumed by UDS…
- CVE-2026-10611 — Critical (CVSS 10.0): An authentication bypass vulnerability exists in MISP when LDAP mixed authentication is enabled with OTP enforcement.…
- CVE-2026-47280 — Critical (CVSS 10.0): Improper authentication in Azure Resource Manager (ARM) allows an unauthorized attacker to elevate privileges over a…
- CVE-2026-42822 — Critical (CVSS 10.0): Improper authentication in Azure Local Disconnected Operations allows an unauthorized attacker to elevate privileges…
- CVE-2026-20182 — Critical (CVSS 10.0): May 2026: This security advisory provides the details and fix information for a vulnerability that was discovered and…
Browse all CWE-287 (Improper Authentication) vulnerabilities →